Literature DB >> 6608629

Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor.

S K Kops, H Van Loveren, R W Rosenstein, W Ptak, P W Askenase.   

Abstract

Previous studies have shown that T cell-dependent activation of mast cells to release serotonin is required for the elicitation of delayed-type hypersensitivity in mice. We have recently described an antigen-binding T cell factor that is a suitable candidate for participation in the mechanism by which T cells activate mast cells in delayed-type hypersensitivity. The T cell factor transfers the ability to elicit an antigen-specific immediate hypersensitivity-like ear-swelling reaction following local challenge with antigen. In the current study, alterations in the morphology of local tissue mast cells and vessels were studied by light and electron microscopy at the time of optimal swelling and increase in vascular permeability. Factor-induced reactions showed mild changes in metachromatic staining of mast cell granules compared with more profound changes that were found in reactions of antigen-challenged mice that were sensitized by intravenous injection with IgE antibody. Subtle changes in the ultrastructure of mast cells in reactions induced by the T cell factor included surface activation to form filopodial extensions, resulting in a significant increase in the surface density by stereologic analysis. The cytoplasm of these mast cells also showed signs of synthetic and metabolic activity with formation of vesicles and an increased prominence of the Golgi apparatus and mitochondria. Local vessels at sites of reactions due to the T cell factor or IgE showed intravascular accumulation of polymorphonuclear leukocytes, gaps at sites of endothelial cell junctions, and occasional emigration of the leukocytes into the perivascular area. This indicates that a vasoactive factor, such as serotonin, and chemotactic factors were released in both instances. However, in recipients of the T cell factor, this was accomplished with only moderate signs of overt mast cell degranulation and loss of granule density. Instead, there was formation of vesicles at the outer margin of the granules, in the perigranular membrane, and in the cytoplasm, accompanied by the surface activation. In contrast, mast cells from reactions in IgE-sensitized animals appeared to degranulate by a process of sequential compound exocytosis with no vesicle formation or cytoplasmic findings of increased synthetic or metabolic activity. The granules of these cells showed a great loss of density and many appeared swollen, resulting in overall swelling and increase in area of the cell.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608629

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  19 in total

1.  Bronchoalveolar mast cells in sarcoidosis: increased numbers and accentuation of mediator release.

Authors:  K C Flint; K B Leung; B N Hudspith; J Brostoff; F L Pearce; D Geraint-James; N M Johnson
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

2.  Early alteration of synovial membrane in osteoarthrosis.

Authors:  F P Cantatore; F Benazzo; D Ribatti; G Lapadula; S D'Amico; A Tursi; V Pipitone
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

3.  Lymphatic mast cells in response to in vitro stimulation by non-specific T-cell mitogens.

Authors:  K Włodarski; G Rychlik; S Mazur
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

Review 4.  Mast cells, fibroblasts, and fibrosis. New clues to the riddle of mast cells.

Authors:  K L Choi; H N Claman
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

5.  Skin reactivity of unsensitized monkeys upon challenge with staphylococcal enterotoxin B: a new approach for investigating the site of toxin action.

Authors:  P H Scheuber; J R Golecki; B Kickhöfen; D Scheel; G Beck; D K Hammer
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

6.  Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity.

Authors:  G P Geba; W Ptak; P W Askenase
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

Review 7.  Mechanisms of pain in chronic pelvic pain syndrome: influence of prostatic inflammation.

Authors:  Aare Mehik; Markku J Leskinen; Pekka Hellström
Journal:  World J Urol       Date:  2003-04-17       Impact factor: 4.226

8.  Regulation of delayed-type hypersensitivity-like responses in the mouse lung, determined with histological procedures: serotonin, T-cell suppressor-inducer factor and high antigen dose tolerance regulate the magnitude of T-cell dependent inflammatory reactions.

Authors:  J Garssen; F P Nijkamp; S S Wagenaar; A Zwart; P W Askenase; H Van Loveren
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

9.  Increased urinary albumin indicating urothelial leakage following intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer.

Authors:  E C de Boer; T M De Reijke; D H Schamhart; P C Vos; K H Kurth
Journal:  Urol Res       Date:  1993

10.  Macrophage infiltration in tumors and tumor-surrounding tissue: influence of serotonin and sensitized lymphocytes.

Authors:  G Los; R A De Weger; D T Van den Berg; R Sakkers; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.